Quick Takeaways
- Ann D. Rhoads has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,741,634.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Ann D. Rhoads and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| GMED | GLOBUS MEDICAL INC | Director | $1,307,640 | -$1,402,600 | -52% | 21 Jan 2026 |
| QDEL | QuidelOrtho Corp | Director | $433,994 | +$21,206 | +5.1% | 10 Dec 2025 |
| RPTX | Repare Therapeutics Inc. | Director | $0 | 28 Jan 2026 | ||
| EVOK | Evoke Pharma Inc | Director | 05 May 2021 | |||
| ITOS | iTeos Therapeutics, Inc. | Director | 29 Aug 2025 | |||
| QDEL | QUIDEL CORP /DE/ | Director | 27 May 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|